Man Group’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Man Group’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-970,598	Closed	-$19.4M	–	2354
2022 Q3	$19.4M	Buy	+970,598	New	+$12.8M	0.09%	261
2022 Q2	–	Hold	0	–	–	–	1914

Man Group's FMTX Position: Q4 2022 in Review

Man Group sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 970,598 shares — an estimated $19.4M sold.

Man Group first reported a position in FMTX in Q3 2022 and held it in 1 quarter. The position peaked at $19.4M in Q3 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

Man Group reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Man Group sold 970,598 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $19.4M.
Man Group first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
Man Group's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $19.4M in Q3 2022.
0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Man Group's 13F filing for Q4 2022, filed 14 Feb 2023.